Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model

Abstract Background Alzheimer’s disease (AD) is characterized by physiologically endogenous proteins amyloid beta (Aβ) and tau undergoing a conformational change and accumulating as soluble oligomers and insoluble aggregates. Tau and Aβ soluble oligomers, which contain extensive β-sheet secondary st...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Krystal Herline, Frances Prelli, Pankaj Mehta, Claire MacMurray, Fernando Goñi, Thomas Wisniewski
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2018-06-01
Serie:	Alzheimer’s Research & Therapy
Soggetti:	Alzheimer’s disease Amyloid-beta (Aβ) Phosphorylated tau Oligomers Passive immunization Monoclonal antibody
Accesso online:	http://link.springer.com/article/10.1186/s13195-018-0384-9
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!